Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,062 | -37,499 | -20,301 | N/A | -50,312 |
| Depreciation Amortization | 6,823 | 4,449 | 2,070 | N/A | 6,274 |
| Accounts receivable | -127 | -576 | -42 | N/A | -18 |
| Accounts payable and accrued liabilities | 757 | 769 | 595 | N/A | 539 |
| Other Working Capital | 997 | 1,621 | 1,142 | N/A | -41 |
| Other Operating Activity | 870 | 2,013 | 1,993 | 0 | 3,185 |
| Operating Cash Flow | $-59,742 | $-29,223 | $-14,543 | $N/A | $-40,373 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -92 | -29 | N/A | -255 |
| Investing Cash Flow | $-175 | $-92 | $-29 | $N/A | $-255 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,659 | 19,659 | 19,659 | N/A | N/A |
| Debt Repayment | -1,277 | -834 | -402 | N/A | -1,107 |
| Common Stock Issued | 596 | 236 | 206 | N/A | 235 |
| Other Financing Activity | 241,459 | -706 | -192 | 0 | 3,251 |
| Financing Cash Flow | $260,437 | $18,355 | $19,271 | $N/A | $2,379 |
| Beginning Cash Position | 39,929 | 39,929 | 39,929 | N/A | 93,713 |
| End Cash Position | 240,449 | 28,969 | 44,628 | N/A | 55,464 |
| Net Cash Flow | $200,520 | $-10,960 | $4,699 | $N/A | $-38,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,742 | -29,223 | -14,543 | N/A | -40,373 |
| Capital Expenditure | -175 | -92 | -29 | N/A | -305 |
| Free Cash Flow | -59,917 | -29,315 | -14,572 | 0 | -40,678 |